OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth
Deisy Segura-Villalobos, Itzel G. Ramírez-Moreno, Magnolia Martínez-Aguilar, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82

Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58

Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
Xiaoxin Liu, Xinyu Li, Haotian Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31

Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition
Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2582-2597
Open Access | Times Cited: 11

The Controversial Role of Intestinal Mast Cells in Colon Cancer
Rosa Molfetta, Rossella Paolini
Cells (2023) Vol. 12, Iss. 3, pp. 459-459
Open Access | Times Cited: 21

Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Yushan Dong, Jingyu Chen, Yuhan Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115513-115513
Open Access | Times Cited: 21

Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
Saimeng Shi, Long‐Yun Ye, Xianjun Yu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188845-188845
Closed Access | Times Cited: 25

HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer
Zhenyu Li, Ran Wei, S. Yao, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24664-e24664
Open Access | Times Cited: 5

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
Roberta Sulsenti, Elena Jachetti
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1692-1692
Open Access | Times Cited: 12

SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironment
Rosa Molfetta, Mario Lecce, Nadia D. Milito, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 12

Siglec-9 is an inhibitory receptor on human mast cells in vitro
Irina Miralda, Nyssa Becker Samanas, Albert J. Seo, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 3, pp. 711-724.e14
Open Access | Times Cited: 11

Mast cell-mediated microRNA functioning in immune regulation and disease pathophysiology
Qiuping Deng, Xin Hua Yao, S L Fang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access

Mast Cell Density in Squamous Cell Carcinoma of Skin in Dogs and Cats
Nomeda Juodžiukynienė, Kristina Lasienė, Nijolė Savickienė, et al.
Animals (2025) Vol. 15, Iss. 3, pp. 316-316
Open Access

Spontaneous Undifferentiated Pleomorphic Sarcoma With Mast Cell Infiltration in a Sprague–Dawley Rat: A Case Report
Jeong‐Hyun Choi, Soo‐Eun Sung, Min Kyung Sung, et al.
Veterinary Medicine and Science (2025) Vol. 11, Iss. 2
Open Access

Hypoxia‐Inducible Factor 1 Alpha Potentiates Lipopolysaccharide‐Induced Expression of IL‐13 and IL‐33 in Mast Cells Under Hypoxia
Norika Chiba, Tomokazu Ohnishi, Tetsuya Matsuguchi
Microbiology and Immunology (2025)
Closed Access

Pro-Tumorigenic Effect of Continuous Cromolyn Treatment in Bladder Cancer
Lucija Franković, Marina Degoricija, Ivana Gabela, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1619-1619
Open Access

Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma
Tatjana Khromov, Maren Sitte, Gabriela Salinas, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Chloride channels and mast cell function: pioneering new frontiers in IBD therapy
Ahmed M. Aljameeli, Bader Alsuwayt, Deepak Bharati, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access

Putative function and prognostic molecular marker of mast cells in colorectal cancer
Jiani Guo, Jie Chen, Yi‐Ting Wang, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access

Association between immune-related hub genes CD36, CXCL13, FGFR4, GABBR1, LAMP3, MMP12, and PPM1H and colorectal cancer prognosis
Liuli Wang
American Journal of Translational Research (2024) Vol. 16, Iss. 1, pp. 216-223
Open Access | Times Cited: 3

Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C
Feifei Song, Youhua Zhang, Qi Chen, et al.
Oncogene (2022) Vol. 42, Iss. 3, pp. 209-223
Closed Access | Times Cited: 14

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
Katerina Kalkusova, Sindija Smite, Elea Darras, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11080-11080
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top